Calidi Biotherapeutics, Inc.

US$0.70As of Sun 8 Nov 2026, 12:00 UTC
AMEX:CLDIHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (87.32%)
Div yield —
ROE (672.22%)
Biotechnology
Beta (5Y) 1.37
PE TTM —
TSR TTM (97.16%)
Mkt cap US$2.587M
ROIC (199.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.888
26.84%
50.00%
Sell 4|1|9|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(4.23%)
7.44%
15.49%
32.27%
Revenue$M
0.218
0.230
0.228
0.234
2.57%
7.37%
6.72%
9.10%
Peers (US$2.587M)
Cap (US$)
PE
2.745M
—
2.349M
—
2.665M
—
Capital
TTM
5Y
10Y
Leveragex
2.141
0.043
0.044
EBIT/Intx
1.346
2.536
2.120
Own earn%
(16.18)
(3.89)
11.82
Sh yield%
24.94
25.42
22.69
Owners
Insiders/Inst%
13.54
56.82
Short interest%
4.78
SBC / revenue%
3.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
0–9
$1 testx
−0.1
Incr. ROIC%
12